🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

PETS PETS

Company Profile ↓
$1.97
-38.44% 1Y
Mkt Cap$42.13M
P/E-0.72
P/B1.46
52W High$3.90
52W Low$1.60
Book Value$1.35
EPS (TTM)$-2.74

Company Overview

PETS (PETS) is a publicly traded company listed on with a market capitalization of $42.13M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Recent Developments

  • Trailing 12 Months Year-on-year growth — revenue -34.7%.
  • 5-Year Trend Long-term compounding — revenue CAGR -1.9%.

Growth & Price Performance

Compounded Sales Growth

5 Years:-1.89%
1 Year:-34.69%

Stock Price Performance

1 Year:-38.44%
6 Months:-37.06%
3 Months:-16.88%
1 Month:+2.60%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed
52-Week Range 16% of range
$1.60 $3.90
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMABelow
  • RSI (14)50.38 · Neutral
Price Performance
1M+2.60%
3M-16.88%
6M-37.06%
1Y-38.44%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

  • Revenue declined at -1.9% CAGR over 5 years.
  • Trading 49.5% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-0.72
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$1.35
Price to Book
1.46
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
-1.89%
Profit 5Y
-
Revenue (YoY)
-34.69%
Earnings (YoY)
-

Profitability & Returns

ROCE
-107.74%
ROE
-
ROA
-70.56%
Profit Margin
-32.00%
Op Margin
-17.55%
Gross Margin
28.05%
EPS (Latest Qtr)
$-0.19
EPS (TTM)
$-2.74

Balance Sheet & Liquidity

Debt/Equity
1.85
Quick Ratio
0.58
Current Ratio
0.84
Debt
$535.00K
Total Assets
$81.19M
Current Assets
$43.56M
Working Capital
$-8.47M

Ownership

Promoter Holding
15.57%
Chg in Prom Hold
0.00%
FII / Inst Holding
44.61%
Chg in FII Hold
0.00%

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$179.02M
EBITDA
$-22.03M
Free Cash Flow
$-33.01M
Operating Cash Flow
$-28.39M
Shares Outstanding
21.39M
Gross Margin
28.05%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Jun 2023Sep 2023Dec 2023Jun 2024Sep 2024Dec 2024Jun 2025Sep 2025Dec 2025Mar 2026
Revenue ---------------------------67.39M63.16M57.24M75.91M69.46M63.67M66.21M58.04M51.96M51.18M44.36M40.66M42.82M
Cost of Revenue -----------------------------------38.08M36.78M31.95M31.20M28.88M
Gross Profit 18.91M16.75M17.66M22.45M18.06M16.64M22.16M27.46M23.48M21.94M24.92M29.95M25.25M19.38M20.72M21.86M20.00M17.70M21.69M26.79M23.02M19.62M20.52M21.78M19.17M17.73M19.40M20.89M20.13M16.57M25.00M21.26M19.42M19.04M18.77M14.91M14.40M12.41M9.46M13.94M
Operating Expenses -----------------------------------15.36M21.28M20.80M19.93M19.63M
Operating Income 7.09M7.62M8.59M10.40M7.73M7.66M11.70M14.42M12.25M11.47M14.00M15.76M13.20M9.41M7.80M6.16M8.37M7.93M8.51M9.44M10.47M9.29M8.39M5.42M8.09M5.15M7.06M3.49M2.96M-769.00K-2.13M875.00K-3.07M4.39M554.00K-450.00K-6.87M-8.38M-10.47M-5.69M
EBITDA -----------------------------------1.14M-4.59M-6.10M-8.07M-3.27M
Interest Expense ----------------------------------------
Pretax Income ------------------------------------242.00K-34.14M-8.51M-10.54M-4.16M
Tax Provision -----------------------------------465.00K9.00K9.00K11.00K-102.00K
Net Income 4.50M4.89M5.42M6.59M4.90M4.82M7.50M9.28M8.76M9.06M10.18M12.58M10.75M7.79M6.62M5.34M6.67M6.84M7.00M7.77M8.41M7.61M6.81M4.43M6.35M4.26M6.07M2.77M2.58M-212.00K-1.14M715.00K-2.03M3.75M2.33M-707.00K-34.15M-8.52M-10.55M-4.06M
Diluted EPS 0.220.240.270.320.240.240.370.450.430.440.500.620.520.380.320.260.330.340.350.390.420.380.340.220.310.210.300.140.13-0.01-0.060.03-0.100.180.11-0.03-1.65-0.41-0.50-0.19

Profit & Loss (Annual)

Figures in USD.

Metric Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 238.27M231.64M238.25M227.83M233.39M229.40M234.68M249.18M273.80M283.42M284.12M309.21M272.28M247.57M274.10M-179.02M
Cost of Revenue ------------195.34M185.84M202.42M-128.81M
Gross Profit 91.86M83.96M80.17M77.12M77.62M76.27M76.30M79.31M97.81M95.31M81.25M89.95M78.08M71.01M78.65M-50.22M
Operating Expenses ------------52.65M70.45M92.93M-81.63M
Operating Income 40.54M33.02M26.02M27.00M28.22M27.61M32.39M37.48M52.14M46.17M30.98M37.59M25.71M-1.43M-8.16M--31.41M
EBITDA ------------27.03M2.12M-1.11M--22.03M
Interest Expense -----------------
Pretax Income ------------24.18M1.58M-6.27M--57.36M
Tax Provision ------------5.97M2.31M1.19M--73.00K
Net Income 26.00M20.87M16.66M17.16M17.97M17.45M20.57M23.82M37.28M37.74M25.85M30.60M21.10M233.00K-7.46M--57.29M
Diluted EPS 1.140.920.800.860.900.871.021.171.821.841.291.52-0.01-0.37-0.30-2.74

Balance Sheet (Annual)

Figures in USD.

Metric Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets --106.29M91.06M73.18M78.38M82.85M90.28M112.81M134.84M154.43M155.32M187.50M179.70M164.12M169.88M148.70M81.19M
Current Assets -------------151.00M130.43M93.65M-43.56M
Cash & Equivalents 30.13M53.14M49.66M46.80M18.16M18.30M35.61M37.64M58.73M77.94M100.53M103.76M118.72M111.08M104.09M55.30M54.72M21.41M
Inventory -------------32.45M19.02M28.56M-13.61M
Receivables -------------1.91M1.74M3.28M-1.91M
Total Liabilities --9.28M9.88M9.16M8.16M7.42M7.08M19.44M19.11M19.75M25.31M46.22M56.25M57.51M73.15M63.57M52.25M
Current Liabilities --8.96M9.39M9.00M8.09M7.42M7.08M18.36M18.11M18.63M24.34M44.94M33.20M36.50M72.16M62.77M52.03M
Long Term Debt ------------------
Total Debt --------------01.45M-535.00K
Total Equity 74.97M96.86M97.00M81.18M64.01M70.22M75.44M83.19M93.37M115.73M134.68M130.01M124.93M142.19M123.80M96.73M85.13M28.94M
Shares Outstanding -------------20.98M21.08M21.15M-21.39M

Cash Flows (Annual)

Figures in USD.

Metric Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow ------21.05M47.20M37.38M45.14M38.84M40.08M18.50M27.80M4.32M4.72M-28.39M
Investing Cash Flow -------4.49M-10.60M-703.00K-620.00K-2.31M-2.43M-1.75M-10.26M-40.67M-5.11M-4.62M
Financing Cash Flow -------14.54M-15.51M-17.47M-21.93M-33.30M-22.69M-24.38M-24.54M-12.44M-181.00K-299.00K
Capital Expenditure -1.05M-667.00K-705.00K-626.00K-45.00K-918.00K-20.13M-10.60M-703.00K-620.00K-2.31M-2.43M-1.75M-5.26M-4.51M-5.11M-4.62M
Free Cash Flow ------923.00K36.60M36.68M44.52M36.53M37.64M16.75M22.54M-194.00K-395.00K-33.01M
Net Change in Cash -------------7.64M-6.99M-48.79M--33.31M
Share Buybacks -12.25M23.68M3.87M-----011.50M00----

Ratios (Annual)

Figures in %.

Metric Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % 38.6%36.2%33.6%33.9%33.3%33.2%32.5%31.8%35.7%33.6%28.6%29.1%28.7%28.7%28.7%-28.1%
Operating Margin % 17.0%14.3%10.9%11.9%12.1%12.0%13.8%15.0%19.0%16.3%10.9%12.2%9.4%-0.6%-3.0%--17.5%
Net Margin % 10.9%9.0%7.0%7.5%7.7%7.6%8.8%9.6%13.6%13.3%9.1%9.9%7.7%0.1%-2.7%--32.0%
ROE % 26.8%21.5%20.5%26.8%25.6%23.1%24.7%25.5%32.2%28.0%19.9%24.5%14.8%0.2%-7.7%--197.9%
ROCE % -33.9%31.9%42.1%40.1%36.6%38.9%39.7%44.7%34.0%23.7%26.4%17.5%-1.1%-8.4%--107.7%

Shareholding Pattern

Insiders
15.57%
Institutions
44.61%
Public Float
52.84%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for PETS

Yahoo Finance Wed, 05 Aug 2026

eBay (EBAY) Q2 Earnings and Revenues Top Estimates

eBay (EBAY) delivered earnings and revenue surprises of +5.96% and +3.85%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Yahoo Finance hu, 30 Jul 2026

PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026

DELRAY BEACH, Fla., July 30, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) today announced it will report financial results for the first quarter fiscal year ended June 30, 2026, …

Yahoo Finance hu, 23 Jul 2026

PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million

DELRAY BEACH, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced that it has entered into a definitive agreement for a sale-leaseback transaction (“Trans…

Yahoo Finance ue, 14 Jul 2026

PetMeds and Rural King Expand Access to Pet Healthcare Through New Online Pharmacy Platform

Rural King customers can now shop medications, prescription food and other pet health products through a co-branded digital experienceDELRAY BEACH, Fla., July 14, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., doing business as PetMeds and …

Yahoo Finance ue, 30 Jun 2026

PetMed Express, Inc. Confirms Receipt of Unsolicited, Non-Binding, and Conditional Acquisition Proposal from SilverCape Investments Limited

DELRAY BEACH, Fla., June 30, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (“PetMeds” or the “Company”) (Nasdaq: PETS) today confirmed that its Board of Directors (the “Board”) has received an unsolicited, non-binding, and conditional propo…

Yahoo Finance Mon, 29 Jun 2026

SilverCape Releases Revised Proposal to Acquire PetMed Express for $3.00 per Share in Cash

Unaccountable Board Led by Chair & Interim CEO Leslie C.G. Campbell Continues to Preside Over Stunning Destruction of Stockholder Value Board’s Failure to Properly Consider Strategic Alternatives Amid Ongoing Erosion of Value Could Leave St…

PETS — Frequently Asked Questions

What is the current share price of PETS?

As of 2026-08-05 17:25 PDT, PETS trades at $1.97 on NASDAQ/NYSE. Its 52-week range is $1.60 to $3.90.

What is the market capitalisation of PETS?

PETS has a market capitalisation of $42.13M on NASDAQ/NYSE.

What is the P/E ratio of PETS?

PETS trades at a trailing price-to-earnings (P/E) ratio of -0.72. Its price-to-book (P/B) ratio is 1.46.

Is PETS a good stock to buy?

This page provides a data-driven analysis of PETS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space